Research output

Research output per year 1990 2011 2014 2015 2018 2020 2021 2022 2022

• 74 Article
• 17 Review article
• 11 Letter
• 3 Short survey
• 1 More
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2022

  BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

  Spikes, L. A., Bajwa, A. A., Burger, C. D., Desai, S. V., Eggert, M. S., El-Kersh, K. A., Fisher, M. R., Johri, S., Joly, J. M., Mehta, J., Palevsky, H. I., Ramani, G. V., Restrepo-Jaramillo, R., Sahay, S., Shah, T. G., Deng, C., Miceli, M., Smith, P. & Shapiro, S. M., Apr 2022, In: Pulmonary Circulation. 12, 2, e12063.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • treprostinil 100%
  • Pulmonary Arterial Hypertension 70%
  • Powders 60%
  • Inhalation 56%
  • Clinical Studies 41%

• Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

  Rahaghi, F. F., Balasubramanian, V. P., Bourge, R. C., Burger, C. D., Chakinala, M. M., Eggert, M. S., Elwing, J. M., Feldman, J., King, C., Klinger, J. R., Mathai, S. C., McConnell, J. W., Palevsky, H. I., Restrepo-Jaramillo, R., Safdar, Z., Sager, J. S., Sood, N., Sulica, R., White, R. J. & Hill, N. S., Apr 2022, In: Pulmonary Circulation. 12, 2, e12055.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • riociguat 100%
  • Phosphodiesterase 5 Inhibitors 73%
  • Pulmonary Hypertension 56%
  • Pulmonary Arterial Hypertension 44%
  • Soluble Guanylyl Cyclase 24%

• Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

  LIVE-AIR Study Group, Mar 2022, In: The Lancet Respiratory Medicine. 10, 3, p. 237-246 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pneumonia 100%
  • Placebos 85%
  • Randomized Controlled Trials 83%
  • GS-5734 37%
  • Artificial Respiration 33%

• Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry

  Cajigas, H. R., Burger, C. D., Cartin-Ceba, R., DuBrock, H., Swanson, K., Vargas, H. E., Keaveny, A. P., Watt, K. D. & Krowka, M., Dec 2022, In: Mayo Clinic proceedings. 97, 12, p. 2236-2247 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Registries 100%
  • Pulmonary Arterial Hypertension 99%
  • Hypertension 82%
  • Liver Transplantation 57%
  • Survival 35%

• Utilization of an Electronic Health Record Integrated Risk Score to Predict Hospitalization Among COVID-19 Patients

  Nyman, M. A., Jose, T., Croghan, I. T., Parkulo, M. A., Burger, C. D., Schroeder, D. R., Hurt, R. T. & O’Horo, J. C., Jan 2022, In: Journal of Primary Care and Community Health. 13

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • hospitalization 100%
  • Electronic Health Records 92%
  • utilization 72%
  • Hospitalization 66%
  • electronics 62%
• 2021

  A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine: A Special Report by the Association of Pulmonary and Critical Care Medicine Program Directors

  Consensus Expert Panel (CEP) Members, Feb 2021, In: Chest. 159, 2, p. 733-742 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Psychological Burnout 100%
  • Critical Care 74%
  • Medicine 62%
  • Depression 56%
  • Lung 45%
  2 Scopus citations

• Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer

  Helgeson, S. A., Waddle, M. R., Burnside, R. C., Debella, Y. T., Lee, A. S., Burger, C. D., Li, Z., Johnson, P. W. & Patel, N. M., 2021, In: Southern medical journal. 114, 9, p. 607-613 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Angiotensin Receptor Antagonists 100%
  • Angiotensin-Converting Enzyme Inhibitors 87%
  • Lung Neoplasms 70%
  • Confidence Intervals 44%
  • Delivery of Health Care 18%

• Clinical differences and outcomes between methamphetamine-associated and idiopathic pulmonary arterial hypertension in the pulmonary hypertension association registry

  the Pulmonary Hypertension Association Registry Investigators, Apr 2021, In: Annals of the American Thoracic Society. 18, 4, p. 613-622 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Familial Primary Pulmonary Hypertension 100%
  • Methamphetamine 89%
  • Pulmonary Arterial Hypertension 81%
  • Pulmonary Hypertension 75%
  • Registries 60%
  1 Scopus citations

• Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension

  Cartin-Ceba, R., Burger, C., Swanson, K., Vargas, H., Aqel, B., Keaveny, A. P., Heimbach, J., Taner, T., Nyberg, S., Rosen, C., Cajigas, H., Dubrock, H. & Krowka, M. J., 2021, (Accepted/In press) In: Transplantation. p. 2283-2290 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Liver Transplantation 100%
  • Hypertension 71%
  • Lung 29%
  • Vascular Resistance 26%
  • Survival 22%

• Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

  DuBrock, H. M., Burger, C. D., Bartolome, S. D., Feldman, J. P., Ivy, D. D., Rosenzweig, E. B., Sager, J. S., Presberg, K. W., Mathai, S. C., Lammi, M. R., Klinger, J. R., Eggert, M., De Marco, T., Elwing, J. M., Badesch, D., Bull, T. M., Cadaret, L. M., Ramani, G., Thenappan, T., Ford, H. J., & 10 othersAl-Naamani, N., Simon, M. A., Mazimba, S., Runo, J. R., Chakinala, M., Horn, E. M., Ryan, J. J., Frantz, R. P., Krowka, M. J. & on behalf of the PHAR Investigators, B. O. T. PHAR. I., 2021, In: Pulmonary Circulation. 11, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Familial Primary Pulmonary Hypertension 100%
  • Pulmonary Hypertension 75%
  • Registries 60%
  • Hypertension 49%
  • Health 37%

• Obesity in pulmonary arterial hypertension the pulmonary hypertension association registry

  Min, J., Feng, R., Badesch, D., Berman-Rosenzweig, E., Burger, C., Chakinala, M., De Marco, T., Feldman, J., Hemnes, A., Horn, E. M., Lammi, M., Mathai, S., McConnell, J. W., Presberg, K., Robinson, J., Sager, J., Shlobin, O., Simon, M., Thenappan, T., Ventetuolo, C., & 1 othersAl-Naamani, N., Feb 1 2021, In: Annals of the American Thoracic Society. 18, 2, p. 229-237 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Hypertension 84%
  • Registries 67%
  • Obesity 59%
  • Overweight 34%

• Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

  O'Horo, J. C., Cerhan, J. R., Cahn, E. J., Bauer, P. R., Temesgen, Z., Ebbert, J., Abril, A., Abu Saleh, O. M., Assi, M., Berbari, E. F., Bierle, D. M., Bosch, W., Burger, C. D., Cano Cevallos, E. J., Clements, C. M., Carmona Porquera, E. M., Castillo Almeida, N. E., Challener, D. W., Chesdachai, S., Comba, I. Y., & 58 othersCorsini Campioli, C. G., Crane, S. J., Dababneh, A. S., Enzler, M. J., Fadel, H. J., Ganesh, R., De Moraes, A. G., Go, J. R., Gordon, J. E., Gurram, P. R., Guru, P. K., Halverson, E. L., Harrison, M. F., Heaton, H. A., Hurt, R., Kasten, M. J., Lee, A. S., Levy, E. R., Libertin, C. R., Mallea, J. M., Marshall, W. F., Matcha, G., Meehan, A. M., Franco, P. M., Morice, W. G., O'Brien, J. J., Oeckler, R., Ommen, S., Oravec, C. P., Orenstein, R., Ough, N. J., Palraj, R., Patel, B. M., Pureza, V. S., Pickering, B., Phelan, D. M., Razonable, R. R., Rizza, S., Sampathkumar, P., Sanghavi, D. K., Sen, A., Siegel, J. L., Singbartl, K., Shah, A. S., Shweta, F. N. U., Speicher, L. L., Suh, G., Tabaja, H., Tande, A., Ting, H. H., Tontz, R. C., Vaillant, J. J., Vergidis, P., Warsame, M. Y., Yetmar, Z. A., Zomok, C. D., Williams, A. W. & Badley, A. D., Mar 2021, In: Mayo Clinic proceedings. 96, 3, p. 601-618 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Intensive Care Units 21%
  • Mortality 13%
  • Hospitalization 13%
  • Pandemics 9%
  3 Scopus citations

• Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

  Regeneron Genetics Center, PAH Biobank Enrolling Centers’ Investigators, NIHR BioResource for Translational Research - Rare Diseases & National Cohort Study of Idiopathic and Heritable PAH, Dec 2021, In: Genome medicine. 13, 1, 80.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Arterial Hypertension 100%
  • Platelet-Derived Growth Factor 98%
  • 7-(N-(3-aminopropyl)amino)heptan-2-one 39%
  • Genes 34%
  • Bone Morphogenetic Protein Receptors 27%

• United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics

  USPHSR Investigators, Jan 2021, In: Chest. 159, 1, p. 311-327 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Hypertension 84%
  • Registries 67%
  • 7-(N-(3-aminopropyl)amino)heptan-2-one 44%
  • Familial Primary Pulmonary Hypertension 27%
  1 Scopus citations
• 2020

  Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry

  PHAR Investigators, Sep 2020, In: Journal of Heart and Lung Transplantation. 39, 9, p. 945-953 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Hypertension 84%
  • Registries 67%
  • Hemodynamics 62%
  • Lung Compliance 44%
  3 Scopus citations

• Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial

  Preston, I. R., Burger, C. D., Bartolome, S., Safdar, Z., Krowka, M., Sood, N., Ford, H. J., Battarjee, W. F., Chakinala, M. M., Gomberg-Maitland, M. & Hill, N. S., May 2020, In: Journal of Heart and Lung Transplantation. 39, 5, p. 464-472 9 p.

  Research output: Contribution to journal › Article › peer-review

  • ambrisentan 100%
  • Hypertension 37%
  • Pulmonary Arterial Hypertension 34%
  • Vascular Resistance 18%
  • Edema 15%
  3 Scopus citations

• A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care

  Lee, J. D., Burger, C. D., Delossantos, G. B., Grinnan, D., Ralph, D. D., Rayner, S. G., Ryan, J. J., Safdar, Z., Ventetuolo, C. E., Zamanian, R. T. & Leary, P. J., Dec 2020, In: Annals of the American Thoracic Society. 17, 12, p. 1576-1582 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Hypertension 84%
  • Incidence 41%
  • Coronavirus 11%
  • Investigational Therapies 11%
  8 Scopus citations

• GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

  Temesgen, Z., Assi, M., Shweta, F. N. U., Vergidis, P., Rizza, S. A., Bauer, P. R., Pickering, B. W., Razonable, R. R., Libertin, C. R., Burger, C. D., Orenstein, R., Vargas, H. E., Palraj, R., Dababneh, A. S., Chappell, G., Chappell, D., Ahmed, O., Sakemura, R., Durrant, C., Kenderian, S. S., & 1 othersBadley, A. D., Nov 2020, In: Mayo Clinic proceedings. 95, 11, p. 2382-2394 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus 100%
  • Granulocyte-Macrophage Colony-Stimulating Factor 83%
  • Pneumonia 64%
  • Cohort Studies 54%
  • Investigational New Drug Application 9%
  18 Scopus citations

• Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients with a Mean Pulmonary Arterial Pressure ≥35 mm Hg

  Dubrock, H. M., Runo, J. R., Sadd, C. J., Burger, C. D., Cartin-Ceba, R., Rosen, C. B., Taner, T., Nyberg, S. L., Heimbach, J. K., Findlay, J. Y. & Krowka, M. J., 2020, (Accepted/In press) In: Transplantation Direct. e630.

  Research output: Contribution to journal › Article › peer-review

  • Liver Transplantation 100%
  • Arterial Pressure 88%
  • Pulmonary Arterial Hypertension 86%
  • Hypertension 71%
  • Lung 58%
• 2019

  Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

  UK NIHR BioResource Rare Diseases Consortium, UK PAH Cohort Study Consortium & US PAH Biobank Consortium, Mar 2019, In: The Lancet Respiratory Medicine. 7, 3, p. 227-238 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Arterial Hypertension 100%
  • Genome-Wide Association Study 88%
  • HLA-DPA1 antigen 70%
  • Meta-Analysis 63%
  • HLA-DPB1 antigen 62%
  37 Scopus citations

• Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

  Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D. & Frantz, R. P., Aug 2019, In: Chest. 156, 2, p. 323-337 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Arterial Hypertension 100%
  • Risk Assessment 70%
  • Registries 59%
  • Survival 47%
  • Pulmonary Hypertension 46%
  121 Scopus citations

• Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension

  Ray, J. C., Burger, C., Mergo, P., Safford, R., Blackshear, J., Austin, C., Fairweather, D. L., Heckman, M. G., Zeiger, T., Dubin, M. & Shapiro, B., Oct 1 2019, In: International Journal of Cardiovascular Imaging. 35, 10, p. 1881-1892 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Vascular Stiffness 99%
  • Magnetic Resonance Imaging 56%
  • Lung 45%
  • Vascular Remodeling 8%
  9 Scopus citations
• 2018

  In situ analysis of mTORC1/2 and cellular metabolism–related proteins in human Lymphangioleiomyomatosis

  Krencz, I., Sebestyen, A., Papay, J., Jeney, A., Hujber, Z., Burger, C. D., Keller, C. A. & Khoor, A., Sep 2018, In: Human Pathology. 79, p. 199-207 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphangioleiomyomatosis 100%
  • Proteins 24%
  • Metabolic Networks and Pathways 20%
  • S 6 18%
  • Smooth Muscle Myocytes 17%
  7 Scopus citations

• Multidisciplinary perioperative management of pulmonary arterial hypertension in patients undergoing noncardiac surgery

  Díaz-Gómez, J. L., Ripoll, J. G., Mira-Avendano, I., Moss, J. E., Divertie, G. D., Frank, R. D. & Burger, C. D., Jan 1 2018, In: Southern medical journal. 111, 1, p. 64-73 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Hypertension 21%
  • Anesthetics 18%
  • Cardiac Catheterization 11%
  • Vascular Diseases 10%
  2 Scopus citations

• Prostacyclin use among patients with pulmonary arterial hypertension in the United States: A retrospective analysis of a large health care claims database

  Burger, C. D., Pruett, J. A., Lickert, C. A., Berger, A., Murphy, B. & Drake, W., Mar 1 2018, In: Journal of Managed Care and Specialty Pharmacy. 24, 3, p. 291-302 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • hypertension 100%
  • Pulmonary Arterial Hypertension 94%
  • Epoprostenol 90%
  • health care 57%
  • Delivery of Health Care 48%
  14 Scopus citations

• Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension

  Enderby, C. Y. & Burger, C., Sep 1 2018, In: Therapeutic Advances in Chronic Disease. 9, 9, p. 171-177 7 p.

  Research output: Contribution to journal › Article › peer-review

  • treprostinil 100%
  • Pulmonary Arterial Hypertension 70%
  • Physicians 7%
  • Epoprostenol 6%
  • Vital Signs 6%

• Treatment patterns and associated health care costs before and after treatment initiation among pulmonary arterial hypertension patients in the United States

  Burger, C. D., Ozbay, A. B., Lazarus, H. M., Riehle, E., Montejano, L. B., Lenhart, G. & White, R. J., Aug 1 2018, In: Journal of Managed Care and Specialty Pharmacy. 24, 8, p. 834-842 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Guanylate Cyclase Activator 100%
  • Endothelin Receptor Antagonist 92%
  • Phosphodiesterase V Inhibitor 85%
  • hypertension 68%
  • Pulmonary Arterial Hypertension 64%
  13 Scopus citations
• 2017

  A Phase II clinical trial of an aromatase inhibitor for postmenopausal women with lymphangioleiomyomatosis

  Lu, C., Lee, H. S., Pappas, G. P., Dilling, D. F., Burger, C. D., Shifren, A., Veeraraghavan, S., Chapman, J. T., Parambil, J., Ruoss, S. J., Young, L. R., Hammes, S. R., Kopras, E. J., Roads, T., Krischer, J. P. & McCormack, F. X., Jun 2017, In: Annals of the American Thoracic Society. 14, 6, p. 919-928 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphangioleiomyomatosis 100%
  • Letrozole 93%
  • Aromatase Inhibitors 84%
  • Phase II Clinical Trials 82%
  • Sirolimus 48%
  16 Scopus citations

• High-risk echocardiographic features predict mortality in pulmonary arterial hypertension

  Austin, C., Burger, C., Kane, G., Safford, R., Blackshear, J., Ung, R., Ray, J., Alsaad, A., Alassas, K. & Shapiro, B., Jul 1 2017, In: American heart journal. 189, p. 167-176 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Mortality 42%
  • Tricuspid Valve Insufficiency 30%
  • Pericardial Effusion 28%
  • Atrial Pressure 14%
  2 Scopus citations

• Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document

  Rahaghi, F. F., Alnuaimat, H. M., Awdish, R. L. A., Balasubramanian, V. P., Bourge, R. C., Burger, C. D., Butler, J., Gregory Cauthen, C., Chakinala, M. M., deBoisblanc, B. P., Eggert, M. S., Engel, P., Feldman, J., Wesley McConnell, J., Park, M., Sager, J. S., Sood, N. & Palevsky, H. I., Sep 2017, In: Pulmonary Circulation. 7, 3, p. 702-711 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • macitentan 100%
  • Pulmonary Arterial Hypertension 65%
  • Physicians 17%
  • Switzerland 7%
  • Drug Interactions 6%
  3 Scopus citations

• The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease

  Bajwa, A. A., Shujaat, A., Patel, M., Thomas, C., Rahaghi, F. & Burger, C. D., 2017, In: Pulmonary Circulation. 7, 1, p. 82-88 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • treprostinil 100%
  • Pulmonary Hypertension 59%
  • Chronic Obstructive Pulmonary Disease 53%
  • Walk Test 36%
  • Safety 35%
  7 Scopus citations
• 2016

  An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension

  Zamanian, R. T., Levine, D. J., Bourge, R. C., De Souza, S. A., Rosenzweig, E. B., Alnuaimat, H., Burger, C., Mathai, S. C., Leedom, N., DeAngelis, K., Lim, A. & De Marco, T., Sep 1 2016, In: Pulmonary Circulation. 6, 3, p. 329-337 9 p.

  Research output: Contribution to journal › Article › peer-review

  • treprostinil 100%
  • Pulmonary Arterial Hypertension 70%
  • Patient Safety 59%
  • Observational Studies 46%
  • United States Food and Drug Administration 13%
  5 Scopus citations

• Can a six-minute walk distance predict right ventricular dysfunction in patients with diffuse parenchymal lung disease and pulmonary hypertension?

  Ussavarungsi, K., Lee, A. S. & Burger, C. D., Sep 2016, In: Oman Medical Journal. 31, 5, p. 345-351 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Right Ventricular Dysfunction 100%
  • Interstitial Lung Diseases 82%
  • Pulmonary Hypertension 75%
  • Arterial Pressure 26%
  • Lung 23%
  1 Scopus citations
• 2015

  Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension

  Austin, C., Alassas, K., Burger, C., Safford, R., Pagan, R., Duello, K., Kumar, P., Zeiger, T. & Shapiro, B., Jan 1 2015, In: Chest. 147, 1, p. 198-208 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Atrial Pressure 100%
  • Pulmonary Arterial Hypertension 97%
  • Mortality 41%
  • Echocardiography 17%
  • Cardiac Catheterization 14%
  48 Scopus citations

• Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis

  Ussavarungsi, K., Hu, X., Scott, J. P., Erasmus, D. B., Mallea, J. M., Alvarez, F., Lee, A. S., Keller, C. A., Ryu, J. H. & Burger, C. D., Oct 1 2015, In: Respiratory Medicine. 109, 10, p. 1354-1359 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphangioleiomyomatosis 100%
  • Lung Transplantation 78%
  • Lung 36%
  • Cystic Disease Of Lung 25%
  • Sirolimus 24%
  12 Scopus citations

• Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. food and drug administration

  Burger, C. D., Jun 1 2015, In: Annals of the American Thoracic Society. 12, 6, p. 959 1 p.

  Research output: Contribution to journal › Article › peer-review

• Prevalence of metabolic syndrome in patients with pulmonary hypertension

  Ussavarungsi, K., Thomas, C. S. & Burger, C. D., 2015, (Accepted/In press) In: Clinical Respiratory Journal.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Hypertension 100%
  • Metabolic Syndrome 92%
  • Pulmonary Arterial Hypertension 47%
  • Familial Primary Pulmonary Hypertension 26%
  • Cardiac Catheterization 10%
  14 Scopus citations

• Prevalence of sodium and fluid restriction recommendations for patients with pulmonary hypertension

  Zeiger, T., Cobo, G. C., Dillingham, C. & Burger, C. D., Sep 2015, In: Healthcare (Switzerland). 3, 3, p. 630-636 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • hypertension 100%
  • Pulmonary Hypertension 79%
  • Sodium 66%
  • instruction 32%
  • counseling 31%

• Survey of restless legs syndrome in a pulmonary hypertension population

  Ussavarungsi, K., Kaplan, J., Burger, C. & Arunthari, V., Jan 1 2015, In: Clinical Respiratory Journal. 9, 1, p. 98-103 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Restless Legs Syndrome 100%
  • Pulmonary Hypertension 76%
  • Population 29%
  • Body Mass Index 9%
  • Pulmonary Arterial Hypertension 8%
  2 Scopus citations
• 2014

  Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry

  Burger, C. D., Long, P. K., Shah, M. R., McGoon, M. D., Miller, D. P., Romero, A. J., Benton, W. W. & Safford, R. E., Nov 1 2014, In: Chest. 146, 5, p. 1263-1273 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Registries 67%
  • Hospitalization 62%
  • Survival 14%
  • P 11 8%
  45 Scopus citations

• Conversion from sildenafil to tadalafil: Results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study

  Frantz, R. P., Durst, L., Burger, C. D., Oudiz, R. J., Bourge, R. C., Franco, V., Waxman, A. B., McDevitt, S. & Walker, S., Nov 11 2014, In: Journal of Cardiovascular Pharmacology and Therapeutics. 19, 6, p. 550-557 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Tadalafil 100%
  • Sildenafil Citrate 86%
  • Pulmonary Arterial Hypertension 80%
  • Patient Satisfaction 16%
  • Phosphodiesterase 5 Inhibitors 11%
  7 Scopus citations

• Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension

  Preston, I. R., Feldman, J., White, J., Franco, V., Ishizawar, D., Burger, C., Waxman, A. B. & Hill, N. S., Sep 2014, In: Pulmonary Circulation. 4, 3, p. 456-461 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • treprostinil 100%
  • Pulmonary Arterial Hypertension 70%
  • Safety 35%
  • Prostaglandins I 14%
  • Parenteral Infusions 6%
  9 Scopus citations

• Screening for connective tissue disease in pulmonary arterial hypertension

  Pagán, R. J., Lee, A. S., Austin, C. O. & Burger, C. D., 2014, In: Southern Medical Journal. 107, 10, p. 666-669 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Connective Tissue Diseases 100%
  • Pulmonary Arterial Hypertension 97%
  • Anti-Idiotypic Antibodies 34%
  • Familial Primary Pulmonary Hypertension 27%
  • Brain Natriuretic Peptide 22%
  2 Scopus citations

• Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity

  Neal, J. E., Lee, A. S. & Burger, C. D., Oct 1 2014, In: Clinical Respiratory Journal. 8, 4, p. 404-409 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Walk Test 100%
  • Pulmonary Arterial Hypertension 97%
  • Pulmonary Artery 75%
  • Brain Natriuretic Peptide 61%
  • Exercise 53%
  6 Scopus citations

• Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: A retrospective case series

  Enderby, C. Y., Soukup, M., Al Omari, M., Zeiger, T. & Burger, C., Oct 2014, In: Journal of Clinical Pharmacy and Therapeutics. 39, 5, p. 496-500 5 p.

  Research output: Contribution to journal › Article › peer-review

  • treprostinil 100%
  • Pulmonary Arterial Hypertension 70%
  • Epoprostenol 68%
  • Patient Transfer 20%
  • Intravenous Infusions 16%
  9 Scopus citations
• 2013

  Electrocardiographic changes in patients responding to treatment with group i pulmonary arterial hypertension

  Snipelisky, D., Burger, C., Shapiro, B. & Kusumoto, F., Nov 1 2013, In: Southern medical journal. 106, 11, p. 618-623 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Electrocardiography 41%
  • Ventricular Pressure 36%
  • Right Ventricular Hypertrophy 22%
  • Blood Pressure 21%
  2 Scopus citations

• Noninvasive assessment of right heart function and hemodynamics during exercise in patients with pulmonary arterial hypertension

  Freeman, M. L., Landolfo, C., Safford, R. E., Keller, C. A., Heckman, M. G. & Burger, C. D., Feb 2013, In: Southern medical journal. 106, 2, p. 141-146 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Pulmonary Artery 77%
  • Hemodynamics 62%
  • Cardiac Catheterization 58%
  • Exercise 55%
  6 Scopus citations
• 2012

  Cystic lung disease is not uncommon in men with tuberous sclerosis complex

  Ryu, J. H., Sykes, A. M. G., Lee, A. S. & Burger, C. D., Nov 2012, In: Respiratory Medicine. 106, 11, p. 1586-1590 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cystic Disease Of Lung 100%
  • Tuberous Sclerosis 72%
  • Lymphangioleiomyomatosis 43%
  • Kidney 21%
  • Chylothorax 13%
  16 Scopus citations
• 2011

  Accuracy and precision of three echocardiographic methods for estimating mean pulmonary artery pressure

  Aduen, J. F., Castello, R., Daniels, J. T., Diaz, J. A., Safford, R. E., Heckman, M. G., Crook, J. E. & Burger, C. D., Feb 1 2011, In: Chest. 139, 2, p. 347-352 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Artery 100%
  • Pressure 71%
  • Cardiac Catheterization 37%
  • Atrial Pressure 11%
  • Pulmonary Hypertension 9%
  36 Scopus citations

• Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term PAH disease management with normative values from the national health and nutrition examination survey

  Burger, C. D., Foreman, A. J., Miller, D. P., Safford, R. E., McGoon, M. D. & Badesch, D. B., Feb 2011, In: Mayo Clinic proceedings. 86, 2, p. 105-112 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Arterial Hypertension 100%
  • Nutrition Surveys 92%
  • Disease Management 84%
  • Registries 67%
  • Body Mass Index 45%
  44 Scopus citations